Conversion to Everolimus-Based Immunosuppression Regimen with Calcineurin Inhibitor Reduction Ameliorates Histological Damage in Kidney Transplant Recipients with Calcineurin Inhibitor-Induced Nephrotoxicity.

被引:0
作者
Hotta, K. [1 ]
Iwahara, N. [1 ]
Tanabe, T. [1 ]
Shinohara, N. [1 ]
机构
[1] Hokkaido Univ Hosp, Sapporo, Hokkaido, Japan
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
D178
引用
收藏
页码:1083 / 1083
页数:1
相关论文
共 50 条
[21]   Sotrastaurin in Calcineurin Inhibitor-Free Regimen Using Everolimus in De Novo Kidney Transplant Recipients [J].
Tedesco-Silva, H. ;
Kho, M. M. L. ;
Hartmann, A. ;
Vitko, S. ;
Russ, G. ;
Rostaing, L. ;
Budde, K. ;
Campistol, J. M. ;
Eris, J. ;
Krishnan, I. ;
Gopalakrishnan, U. ;
Klupp, J. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (07) :1757-1768
[22]   Belatacept-based immunosuppression: A calcineurin inhibitor-sparing regimen in heart transplant recipients [J].
Launay, Manon ;
Guitard, Joelle ;
Dorent, Richard ;
Prevot, Yoann ;
Prion, Florent ;
Beaumont, Laurence ;
Kably, Benjamin ;
Lecuyer, Lucien ;
Billaud, Eliane M. ;
Guillemain, Romain .
AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 (02) :553-563
[23]   Renal Function Outcomes in Kidney Transplant Recipients After Conversion to Everolimus-Based Immunosuppression Regimen with CNI Reduction or Elimination [J].
Cataneo-Davila, A. ;
Zuniga-Varga, J. ;
Correa-Rotter, R. ;
Alberu, J. .
TRANSPLANTATION PROCEEDINGS, 2009, 41 (10) :4138-4146
[24]   Unexpected Early Calcineurin Inhibitor Nephrotoxicity in Pediatric Kidney Transplant Recipients. [J].
Yanik, M. ;
Mannon, R. ;
Seifert, M. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 :750-750
[25]   Short-Term Outcomes of the Calcineurin Inhibitor Avoidance Maintenance Regimen with Everolimus in Kidney Transplant Recipients. [J].
Kutsunai, K. ;
Iwadoh, K. ;
Horibe, T. ;
Ogawa, Y. ;
Kai, K. ;
Murakami, T. ;
Koyama, I. ;
Nakajima, I. ;
Fuchinoue, S. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 :316-316
[26]   Cognitive functioning among heart transplant recipients, receiving calcineurin inhibitor-free, everolimus-based immunosuppression since the early postoperative phase [J].
Burker, B. S. ;
Andersson, S. ;
Gullestad, L. ;
Gude, E. ;
Relbo, A. ;
Grov, I. ;
Malt, U. F. ;
Andreassen, A. ;
Fiane, A. E. ;
Haraldsen, I. R. .
JOURNAL OF PSYCHOSOMATIC RESEARCH, 2015, 78 (06) :595-596
[27]   ULTRALOW DOSE CALCINEURIN INHIBITOR COMBIMED WITH EVEROLIMUS IS AN EFFECTIVE REGIMEN FOR KIDNEY TRANSPLANT RECIPIENT [J].
Lai, Ping Chin ;
Chiu, Ling Yin ;
Huang, Wen Hung .
TRANSPLANT INTERNATIONAL, 2013, 26 :275-275
[28]   Conversion from a calcineurin inhibitor-based immunosuppressive regimen to everolimus in renal transplant recipients: Effect on renal function and proteinuria [J].
Morales, J. ;
Fierro, A. ;
Benavente, D. ;
Zehnder, C. ;
Ferrario, M. ;
Contreras, L. ;
Herzog, C. ;
Buckel, E. .
TRANSPLANTATION PROCEEDINGS, 2007, 39 (03) :591-593
[29]   Evaluation of the efficacy and safety of the conversion from a calcineurin inhibitor to an everolimus-based therapy in maintenance renal transplant patients [J].
Fructuoso, A. Sanchez ;
Millan, J. C. Ruiz San ;
Calvo, N. ;
Rodrigo, E. ;
Moreno, M. A. ;
Cotorruelo, J. ;
Conesa, J. ;
Gomez-Alamillo, C. ;
Arias, M. ;
Barrientos, A. .
TRANSPLANTATION PROCEEDINGS, 2007, 39 (07) :2148-2150
[30]   Outcomes of Conversion From Calcineurin Inhibitor to Belatacept-based Immunosuppression in HLA-sensitized Kidney Transplant Recipients [J].
Sethi, Supreet ;
Najjar, Reiad ;
Peng, Alice ;
Choi, Jua ;
Lim, Kathlyn ;
Vo, Ashley ;
Jordan, Stanley C. ;
Huang, Edmund .
TRANSPLANTATION, 2020, 104 (07) :1500-1507